(S)-ALLYL 2-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-3-HYDROXYPROPANOATE, 95%, 5g

3-[[(1R,2R)-2-(1-Piperidinyl)cyclohexyl]amino]-4-[[4-(trifluoromethyl)phenyl]amino]-3-cyclobutene-1,2-dione, 97%, 100mg

1,2,3,4,5,6-Hexahydrobenzo[b]azocine, 97%, 250mg

Tert-butyln-[3-(trifluoromethyl)-1-bicyclo[1.1.1]pentanyl]carbamate, 98%, 100mg

GC capillary column ROTI®Cap-1 MS, 15 m, 0.25 mm, 0.25 µm, 1 Piece(s)

3-Fluoro-4-(4-methylpiperazin-1-yl)aniline, 95.0%, 25g

3-Hydroxy-3-methyl-2-butanone, 95.0%, 5g

4,6-DIAMINOPYRIMIDINE-5-CARBALDEHYDE, 95%, 250mg

Bis(triphenylphosphino)(2-methylphenyl)chloronickel(II), 98%, 1g

N-o-Tolylformamide, 95.0%, 5g

2,4-Dichloro-N-isopropyl-N-(2-isopropylaminoethyl)benzenesulfonamide, 98%, 10mg

3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one, 97.0%, 25g

5-Methyl-1,3-benzenedicarboxylic acid, 95.0%, 1g